Casey Cosgrove
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Combination Niraparib and Dostarlimab Therapy for Recurrent or Persistent Uterine Serous Carcinoma (NCT05870761) | Casey Cosgrove | 2023-10-17 |
Track Casey Cosgrove automatically
Every clearance here is in the API, with alerts when new ones post.